LCTX Asset Growth
Lineage Cell Therapeutics, Inc. Common Stock · Asset Growth
LCTX Asset Growth
Latest reported-0.56%period ending
LCTX FY Asset Growth (YoY) (0.00% → -0.56%)
Latest values, visible window
High-resolution chart · PNG
LCTX asset growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Asset Growth |
|---|---|
| -0.56% | |
| 12.0759% | |
| -18.3117% | |
| -29.1506% | |
| 61.6921% | |
| -13.9698% | |
| 23.4291% | |
| -41.3187% | |
| 21.5112% | |
| 50.6148% | |
| 26.3803% | |
| 29.744% | |
| 94.0588% | |
| -35.0888% | |
| -13.9715% | |
| 296.5784% | |
| 1,197.3084% | |
| 491.345% | |
| -73.0822% | |
| -66.7903% | |
| 28.7328% | |
| 41.9995% | |
| -28.3765% | |
| -22.937% | |
| 15.7314% | |
| -70.4598% | |
| 102.8087% | |
| -58.209% | |
| 123.3333% | |
| -16.6667% | |
| -38.9831% | |
| 68.5714% | |
| -27.0833% | |
| 0% |